Filing Details
- Accession Number:
- 0001127602-21-023101
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-04 18:18:04
- Reporting Period:
- 2021-08-02
- Accepted Time:
- 2021-08-04 18:18:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1613103 | Medtronic Plc | MDT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1559405 | E Bradley Lerman | 710 Medtronic Pkwy Ms Lc300 Minneapolis MN 55432 | Svp General Counsel & Corp Sec | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2021-08-02 | 4,000 | $131.52 | 48,194 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2021-08-02 | 5,450 | $131.31 | 42,744 | No | 4 | F | Direct | |
| Ordinary Shares | Acquisiton | 2021-08-02 | 6,019 | $0.00 | 48,763 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | F | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (Right to Buy) | Acquisiton | 2021-08-02 | 51,423 | $0.00 | 51,423 | $131.26 |
| Ordinary Shares | Stock Option (Right to Buy) | Acquisiton | 2021-08-02 | 1,085 | $0.00 | 1,085 | $131.26 |
| Performance Share Units | Performance Share Units | Acquisiton | 2021-08-02 | 15,047 | $0.00 | 15,047 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 51,423 | 2022-08-02 | 2031-08-02 | No | 4 | A | Direct |
| 1,085 | 2022-08-02 | 2031-08-02 | No | 4 | A | Direct |
| 15,047 | No | 4 | A | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- This balance increased by 651 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan.
- The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.
- These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
- Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
- The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 15,047 shares will be issued. The actual number of shares to be issued could range from a low of 3,010 at minimum performance to a high of 30,094 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
- Vests on August 2, 2024.
Billionaire Hedge Funds
